A technology that enables biomolecules, such as nucleic acids and proteins, to be imaged at
nanoscale precision throughout preserved 3-D specimens would enable a greater understanding
of life processes and disease detection. This would be beneficial in fields such as neuroscience
and oncology where many complex questions remain unanswered. The ability to map the
locations of specific types of biomolecules within subcellular compartments would give insight into
cellular organization and any altered state in disease. With the advent of expanding microscopy
(ExM), it is now possible to obtain nanoscale images using only a diffraction-limited light
microscope. This simple yet novel approach uses water-swellable polymers to physically expand
biological specimens to be imaged at approximately 70 nm resolution.
While the protocol for expansion and the retention of intracellular antigen have progressed rapidly
since ExM was first developed, currently available methods are limited by linear expansion of 4-
5 times of their original size. A higher expansion factor is needed to reveal the subtle changes in
the size, shape, and texture ratio of subcellular organelles in health status or disease. More
importantly, almost all the current ExM methods require a specific anchoring step to ensure
targeted biomolecules are covalently linked to the newly synthesized hydrogel. A universal
biomolecule anchor that works for thick tissues remains elusive. Additionally, few existing ExM
approaches can expand diverse tissue types other than the brain without losing most of the
epitopes. Thus there is tremendous pent-up demand for a method of nanoscale imaging for
extended 3-D specimens and/or with highly versatile molecular contrast.
Given its potential impact, we now propose a new framework called Magnify to bring the power
and versatility of ExM to next generation. We will focus on the following aspects: (1) Develop a
robust one-shot 11× expansion microscopy with universal biomolecule retention; (2) Further
develop Magnify for expanding mm-scale thick tissues and whole small animals; (3) Extend
Magnify for super-resolution vibrational imaging, including label-free, metabolic and multicolor
super-resolution imaging. We will demonstrate the potential of Magnify as a powerful tool for
mapping subcellular proteomic changes in diverse tissues, cells, and organelles by visualizing
molecular spatial patterns at unprecedented high spatial resolution throughout preserved
specimens.
Public Health Relevance Statement
Public Health Relevance Statement
The research seeks to develop super-resolution imaging technologies that allow for
versatile nanoscale imaging of biological specimens such as cells and tissues. This
would enable profiling of how biomolecules are spatially organized in healthy and
disease states, and discovery of new therapeutic targets.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
052184116
UEI
U3NKNFLNQ613
G4P3TF8PFH73
KZV2XNZZN3A8
MJ5BDF8KMQ43
U9C6D6YR7P69
Project Start Date
01-April-2024
Project End Date
31-March-2028
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$606,056
Direct Costs
$512,703
Indirect Costs
$93,353
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$606,056
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01EB035890-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01EB035890-01
Patents
No Patents information available for 1R01EB035890-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01EB035890-01
Clinical Studies
No Clinical Studies information available for 1R01EB035890-01
News and More
Related News Releases
No news release information available for 1R01EB035890-01
History
No Historical information available for 1R01EB035890-01
Similar Projects
No Similar Projects information available for 1R01EB035890-01